Yang Y - Search Results

1

Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc-/- mice.

Li X, Yang Y, Yuan J, Hong P, Freie B, Orazi A, Haneline LS, Clapp DW. Li X, et al. Among authors: yang y. Blood. 2004 Aug 15;104(4):1204-9. doi: 10.1182/blood-2004-03-1094. Epub 2004 Apr 27. Blood. 2004. PMID: 15113761 Free article.

2

Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution.

Haneline LS, Li X, Ciccone SL, Hong P, Yang Y, Broxmeyer HE, Lee SH, Orazi A, Srour EF, Clapp DW. Haneline LS, et al. Among authors: yang y. Blood. 2003 Feb 15;101(4):1299-307. doi: 10.1182/blood-2002-08-2404. Epub 2002 Oct 10. Blood. 2003. PMID: 12393504 Free article.

3

Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control.

Li X, Plett PA, Yang Y, Hong P, Freie B, Srour EF, Orschell CM, Clapp DW, Haneline LS. Li X, et al. Among authors: yang y. Blood. 2003 Sep 15;102(6):2081-4. doi: 10.1182/blood-2003-02-0536. Epub 2003 May 22. Blood. 2003. PMID: 12763929 Free article.

4

Mesenchymal stem/progenitor cells promote the reconstitution of exogenous hematopoietic stem cells in Fancg-/- mice in vivo.

Li Y, Chen S, Yuan J, Yang Y, Li J, Ma J, Wu X, Freund M, Pollok K, Hanenberg H, Goebel WS, Yang FC. Li Y, et al. Among authors: yang fc, yang y. Blood. 2009 Mar 5;113(10):2342-51. doi: 10.1182/blood-2008-07-168138. Epub 2009 Jan 7. Blood. 2009. PMID: 19129541 Free PMC article.

5

Fanconi anemia signaling network regulates the spindle assembly checkpoint.

Nalepa G, Enzor R, Sun Z, Marchal C, Park SJ, Yang Y, Tedeschi L, Kelich S, Hanenberg H, Clapp DW. Nalepa G, et al. Among authors: yang y. J Clin Invest. 2013 Sep;123(9):3839-47. doi: 10.1172/JCI67364. Epub 2013 Aug 15. J Clin Invest. 2013. PMID: 23934222 Free PMC article.

6

Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.

Yang FC, Ingram DA, Chen S, Zhu Y, Yuan J, Li X, Yang X, Knowles S, Horn W, Li Y, Zhang S, Yang Y, Vakili ST, Yu M, Burns D, Robertson K, Hutchins G, Parada LF, Clapp DW. Yang FC, et al. Among authors: yang x, yang y. Cell. 2008 Oct 31;135(3):437-48. doi: 10.1016/j.cell.2008.08.041. Cell. 2008. PMID: 18984156 Free PMC article.

7

Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.

Nebesio TD, Ming W, Chen S, Clegg T, Yuan J, Yang Y, Estwick SA, Li Y, Li X, Hingtgen CM, Yang FC. Nebesio TD, et al. Among authors: yang fc, yang y. Glia. 2007 Apr 1;55(5):527-36. doi: 10.1002/glia.20482. Glia. 2007. PMID: 17236191

8

Aurora A-Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy.

Du J, Yan L, Torres R, Gong X, Bian H, Marugán C, Boehnke K, Baquero C, Hui YH, Chapman SC, Yang Y, Zeng Y, Bogner SM, Foreman RT, Capen A, Donoho GP, Van Horn RD, Barnard DS, Dempsey JA, Beckmann RP, Marshall MS, Chio LC, Qian Y, Webster YW, Aggarwal A, Chu S, Bhattachar S, Stancato LF, Dowless MS, Iversen PW, Manro JR, Walgren JL, Halstead BW, Dieter MZ, Martinez R, Bhagwat SV, Kreklau EL, Lallena MJ, Ye XS, Patel BKR, Reinhard C, Plowman GD, Barda DA, Henry JR, Buchanan SG, Campbell RM. Du J, et al. Among authors: yang y. Mol Cancer Ther. 2019 Dec;18(12):2207-2219. doi: 10.1158/1535-7163.MCT-18-0529. Epub 2019 Sep 17. Mol Cancer Ther. 2019. PMID: 31530649

9

The tumor suppressor CDKN3 controls mitosis.

Nalepa G, Barnholtz-Sloan J, Enzor R, Dey D, He Y, Gehlhausen JR, Lehmann AS, Park SJ, Yang Y, Yang X, Chen S, Guan X, Chen Y, Renbarger J, Yang FC, Parada LF, Clapp W. Nalepa G, et al. Among authors: yang fc, yang x, yang y. J Cell Biol. 2013 Jun 24;201(7):997-1012. doi: 10.1083/jcb.201205125. Epub 2013 Jun 17. J Cell Biol. 2013. PMID: 23775190 Free PMC article.

10

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation.

Torres-Guzmán R, Ganado MP, Mur C, Marugan C, Baquero C, Yang Y, Zeng Y, Bian H, Du J, de Dios A, Puig O, Lallena MJ. Torres-Guzmán R, et al. Among authors: yang y. Oncotarget. 2022 Jul 2;13:864-875. doi: 10.18632/oncotarget.28249. eCollection 2022. Oncotarget. 2022. PMID: 35813283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109,785 results

Search Page

Filters